Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders

doi 10.1021/acsmedchemlett.5b00489.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists

English

CNS Lymphoma Mimicking a Demyelinating Lesion

Journal of Evolution of Medical and Dental Sciences
2015English

MS23.03 Management of CNS Mets in the Era of CNS-Penetrant TKIs (Med Onc and Rad Onco Perspectives)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Discovery of CNS-Like D3r-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Cerebrospinal Fluid Analysis in the Context of CNS Demyelinating Diseases

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2013English

Fatty Acid Amide Hydrolase as a Potential Therapeutic Target for the Treatment of Pain and CNS Disorders

Expert Opinion on Drug Discovery
Drug Discovery
2009English

Allosteric Modulators of GPCRs: A Novel Approach for the Treatment of CNS Disorders

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2009English

Frontiers in CNS Drug Discovery

2013English

Glibenclamide for the Treatment of Acute CNS Injury

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy